Stock · PM · Consumer Defensive
United States · Large Cap · listed since 2008 · Revenue 12 mo. $43.1B
Price as of 11/06/2026
Summary
47.2 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €9.6B (2025), it supports €106.3B. The remaining €171.1B of the market value assume it grows 13.4% a year for 10 years and not at all afterwards.
Required FCF growth per year
13.4%
no growth afterwards
Price to operating cash flow 20.4×, above its usual range.
Middle half of 20 quarters: 13.7× to 20.0×, median 16.2×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
AI summary of the 2025 annual report
A language model selected and condensed statements from the report. Each statement carries a verbatim quote. The selection is not complete and shows the state of the report. It gives no rating and does not feed into the score.
Form 10-K, fiscal year ended 12/31/2025, filed 02/06/2026. Open the report at the SEC
| Segment | Share | Revenue |
|---|---|---|
| Europe | 42.1% | $17.1B |
| SSEA, CIS & MEA | 29.6% | $12.1B |
| EA, AU & PMI GTR | 16.3% | $6.6B |
| Americas | 11.9% | $4.9B |
From the report's structured data (XBRL), not from the language model. The sum can differ slightly from group revenue.
The company sells cigarettes in about 170 markets. In many of these markets, its cigarettes hold first or second place by market share.
Our cigarettes are sold in approximately 170 markets, and in many of these markets they hold the number one or number two market share position.Marlboro, the world's best-selling international cigarette, accounted for about 43% of total cigarette shipment volume in 2025.
Marlboro, the world’s best-selling international cigarette, which accounted for approximately 43% of our total 2025 cigarette shipment volume.As of December 31, 2025, the company's smoke-free products were sold in 106 markets.
As of December 31, 2025, our smoke-free products were available for sale in 106 markets.The IQOS brand range includes heated tobacco and nicotine-containing vapor products.
Our IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products.The strategy of the wellness unit Aspeya currently focuses mainly on developing and selling oral consumer wellness products.
The business strategy of our wellness unit, Aspeya, currently focuses on developing and commercializing primarily oral consumer wellness offerings.In many markets, the company sells its products to distributors.
in many of our markets we sell our products to distributors.One sales method is direct sales, where the company sells directly to retailers.
Direct sales and distribution, where we sell directly to the retailersThe company also sells smoke-free products and accessories directly to consumers through its own brand retail infrastructure.
Our own brand retail infrastructure for our SFPs and accessories for sales to consumers.The company competes mainly on product quality, brand recognition and loyalty, taste, research and development, innovation, packaging, customer service, marketing, advertising and retail price.
We compete primarily on the basis of product quality, brand recognition, brand loyalty, taste, R&D, innovation, packaging, customer service, marketing, advertising and retail price.Competitors include Altria Group, British American Tobacco, Japan Tobacco and Imperial Brands, as well as new market entrants, especially in innovative products.
Competitors in our industry include Altria Group, Inc., British American Tobacco plc, Japan Tobacco Inc., Imperial Brands plc, new market entrants, particularly with respect to innovative productsSome competitors have different profit, volume and regulatory goals. Some international competitors may be less affected by currency rate changes than the company.
Some of our competitors have different profit, volume and regulatory objectives, and some international competitors may be less susceptible than PMI to changes in currency exchange rates.In 2025, sales to one distributor in the Europe region and one in the EA, AU and PMI GTR region each reached at least 10 percent of consolidated net revenues.
In 2025, sales to a distributor in the Europe Region and a distributor in the EA, AU & PMI GTR Region each amounted to 10 percent or more of our consolidated net revenues.A long disruption or shutdown at one or more production sites, including the ZYN plant in Kentucky, USA, which supplies substantially all of the company's US ZYN capacity.
A prolonged disruption at or shut-down of one or more of the facilities where our products or product components are produced, or sourced from, especially our ZYN production facility in Kentucky, U.S., which currently supplies substantially all of our capacity for ZYN sales in the U.S.Because the portfolio leans toward premium-priced cigarettes, taxes based on sales price can put the company at a competitive disadvantage in certain markets.
Because our portfolio is weighted toward the premium-price cigarette category, tax regimes based on sales price can place us at a competitive disadvantage in certain markets.Since the last quarter
Q2 → Q3 2026
5 more unchanged: Revenue, 12 mo., Gross margin, EBIT margin, Net debt, Shares outstanding
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | −112.19% | 12.35% | Rank 1 |
| Return on capital (Greenblatt) | 177.35% | 20.14% | Rank 97 |
| EBIT margin | 36.64% | 9.44% | Rank 98 |
| FCF margin | 26.23% | 6.71% | Rank 98 |
| Gross margin | 67.12% | 35.78% | Rank 95 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 7.31% | 2.12% | Rank 83 |
| Earnings growth, 3 years per year | 7.70% | 5.20% | Rank 54 |
| Earnings growth, 5 years per year | 7.09% | 6.07% | Rank 51 |
| Sustainable growth (ROE × retained earnings) | 3.86% | 3.77% | Rank 53 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 3.68% | 4.25% | Rank 38 |
| FCF yield | 3.45% | 5.05% | Rank 24 |
| EV/saleslower is better | 8.69 | 1.51 | Rank 3 |
| EV/EBITlower is better | 23.71 | 16.74 | Rank 27 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 22.40% | 3.24% | Rank 82 |
| Share price, 6 months | 16.21% | 11.30% | Rank 70 |
| Share price, 3 months | 9.51% | 9.00% | Rank 54 |
| Distance from 52-week high | −6.34% | −7.96% | Rank 58 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | 5.50% | −0.99% | Rank 9 |
| Change in share countlower is better | 0.13% | −0.62% | Rank 13 |
| Dividend streak in years | 13 | 5 | Rank 81 |
| Price reaction to results, market-adjusted | −1.75% | 0.22% | Rank 28 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | −14.45% | 41.95% | Rank 0 |
| Net debt/EBITDAlower is better | 2.35 | 1.96 | Rank 38 |
| Debt to equitylower is betterdoes not count towards the rank | −5.72 | 0.67 | |
| Volatility, 1 yearlower is better | 28.02% | 25.82% | Rank 34 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $B | Shares | Net debt, $B |
|---|---|---|---|---|---|
| 2016 | 26.7 | 40.9% | 6.9 | 1.55B | 24.8 |
| 2017 | 28.7 | 40.3% | 7.4 | 1.55B | 25.9 |
| 2018 | 29.6 | 38.3% | 8.0 | 1.56B | 25.2 |
| 2019 | 29.8 | 35.3% | 9.2 | 1.56B | 24.2 |
| 2020 | 28.7 | 40.8% | 9.2 | 1.56B | 24.3 |
| 2021 | 31.4 | 9.4% | 11.2 | 1.56B | −1.5 |
| 2022 | 31.8 | 38.6% | 9.7 | 1.55B | 39.9 |
| 2023 | 35.2 | 32.9% | 7.9 | 1.55B | 44.8 |
| 2024 | 37.9 | 35.4% | 10.8 | 1.56B | 41.5 |
| 2025 | 40.6 | 36.6% | 10.7 | 1.56B | 44.0 |
3 of 7 StockScorer Score rules met · How the score is built
Philip Morris International Inc mainly meets criteria in the Momentum category. Result from 18 strategies checked.
Philip Morris International Inc is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
5 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Philip Morris International Inc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 27.2 | 22.8 |
| P/B ratio | −33.7 | 2.6 |
| Return on equity (ROE) | −112.2% | 12.3% |
| Equity ratio | −14.4% | 42.0% |
| Debt-to-equity (D/E) | −5.72 | 0.67 |
| Dividend yield | 3.0% | 2.6% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| PM | Philip Morris International Incthis page | |
| MO | Altria Group | High6.4 |
| BATS.L | British American Tobacco PLC | locked |
| 2914.T | Japan Tobacco Inc | locked |
| ITC.NS | ITC Limited | locked |
| IMB.L | Imperial Brands PLC | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.